ACE2 and inflammatory bowel disease: As such, an early study reported higher levels of circulating ACE2 activity, estimated by an enzymatic assay, in patients with IBD compared to controls [82], whereas in a more recent study, serum sACE2 levels, estimated by ELISA, changed minimally in IBD patients [78].